VACCINE COMPOSITIONS AND THEIR USE
The invention relates to immunogenic compositions and their use as a vaccine for the prevention of coronavirus disease in a human subject. More specifically, the invention relates to methods of use of an immunogenic composition in the prevention of coronavirus disease in a human subject in need ther...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French |
Published |
29.06.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to immunogenic compositions and their use as a vaccine for the prevention of coronavirus disease in a human subject. More specifically, the invention relates to methods of use of an immunogenic composition in the prevention of coronavirus disease in a human subject in need thereof, said immunogenic composition comprising: a fusion protein comprising (i) a SARS-Cov2 nucleocapsid N antigen and, (ii) a carrier protein comprising a self-assembling polypeptide derived from C4bp oligomerization domain and a positively charged tail.
L'invention concerne des compositions immunogènes et l'utilisation de celles-ci en tant que vaccin pour la prévention de la maladie à coronavirus chez un sujet humain. Plus spécifiquement, l'invention concerne des méthodes d'utilisation d'une composition immunogène dans la prévention de la maladie à coronavirus chez un sujet humain en ayant besoin, ladite composition immunogène comprenant : une protéine de fusion comprenant (i) un antigène N de nucléocapside du SARS-Cov2 et (ii) une protéine porteuse comprenant un polypeptide à auto-assemblage, dérivé du domaine d'oligomérisation C4bp, et une queue chargée positivement. |
---|---|
Bibliography: | Application Number: CA20223242433 |